Sitemap
May 09, 2008 Articles
Filter by Available Specialty
- Alimera, pSivida begin trial enrollment for drug implant in patients treated with ranibizumab
- Inspire reports $25.9 million net loss for first quarter, 35% rise in total revenue
- Regeneron and Bayer begin enrollment for second phase 3 trial of VEGF Trap-Eye
- Study: Family history, older age associated with visual field loss at time of glaucoma diagnosis
- Understanding Generation Y will help in training the next group of orthopedists